// App-Quantinova.ai

TCT-91 : Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis.

Researchers

Presenter

  • Ariel Roguin

Principal Investigators

  • David Kandzari

  • Erez Marcusohn

  • Jacques J. Koolen

  • Gheorghe Doros

  • Joseph Massaro

  • Hector Garcia-Garcia

  • Johan Bennett

  • Elie Gharib

  • Donald Cutlip

  • Ron Waksman

Medical Centers

  • Medstar Washington Hospital Center, Washington, District of Columbia, United States

  • Boston University School of Public Health, Boston, Massachusetts, United States

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • UNIVERSITY HOSPITALS LEUVEN, Leuven, Belgium

  • Rambam, Haifa, Israel

  • Baim Institute for Clinical Research, Boston, Massachusetts, United States

  • Charleston Area Medical Center, Charleston, West Virginia, United States

  • Catharina hospital, Eindhoven, Netherlands

Locations

  • United States

  • Netherlands

  • Israel

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • sirolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved